NCT03908385View on ClinicalTrials.gov

Hemoglobin Desaturation in Sickle Cell Disease

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

March 23, 2018

Primary Completion Date

February 1, 2022

Study Completion Date

February 1, 2022

Conditions
Sickle Cell Disease
Trial Locations (1)

44106

University Hospitals Cleveland Medical Center, Cleveland

All Listed Sponsors
lead

University Hospitals Cleveland Medical Center

OTHER

NCT03908385 - Hemoglobin Desaturation in Sickle Cell Disease | Biotech Hunter | Biotech Hunter